TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | 5 | 7 | 9 | 20 | -75 | 0 | -7 |
| P | %wins | 100 | 100 | 50 | 50 | 0 | 60 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/18/16 20:53 | 3/14/16 | STEM | Stemcells Inc | DE | Health | BioPrd | Biological Products, (No Diag | Schiffman Gregory T | CA | O | CFO | P.ad | 50 | 0.3000 | 0 | 166 | 11 | 1,621 | D | -81 | -76 | -44 | -30 | -41 | -8 | -4 | 0 | 0 | 5 | -11 | -99 | -75 | |
11/7/11 17:52 | 11/7/11 | DNDN | Dendreon Corp | DE | Health | Drug | Pharmaceutical Preparations | Schiffman Gregory T | WA | O | CFO,SVP | P | 200 | 6.66 | 33 | 30 | 14 | 242 | D | -76 | -81 | -83 | -35 | -34 | -28 | -33 | -37 | 9 | 8 | 29 | 139 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |